{"id":"W2564858174","doi":"10.1200/jco.2011.29.4_suppl.88","title":"A global, multicenter phase II trial of lapatinib plus capecitabine in gastric cancer.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Lapatinib; Capecitabine; Medicine; Internal medicine; Cancer; Gastroenterology; Oncology; Progressive disease; Tyrosine-kinase inhibitor; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Chemotherapy; Clinical trial; Trastuzumab; Breast cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00250821,0.002683061,0.002039205,0.0006904468,0.0004034527,0.001062178,0.0008100815,0.001260445,0.006004964],"category_scores_gemma":[0.0008578553,0.0007700528,0.001651089,0.0007165372,0.001307985,0.0009674384,0.0006280829,0.003108989,0.001311896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009093531,"about_ca_system_score_gemma":0.00145084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007486384,"about_ca_topic_score_gemma":0.002534814,"domain_scores_codex":[0.9993668,0.0003576734,0.00002272993,0.0001118229,0.00003823633,0.0001027563],"domain_scores_gemma":[0.9995044,0.00006663596,0.0001044074,0.00003770275,0.00003585725,0.0002509252],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9089836,0.01494489,0.00563768,0.001280203,0.001656724,0.0001731532,0.0001355502,0.001032256,0.01252672,0.0001805786,0.005656818,0.0477918],"study_design_scores_gemma":[0.8929581,0.09511204,0.008212225,0.00004439334,0.0005601756,0.0001620838,0.00004117833,0.000329752,0.0005846471,0.0001175848,0.001860481,0.00001736978],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767485,0.007023814,0.0006751406,0.001387602,0.0004380459,0.005090233,0.002980162,0.0002344774,0.00542208],"genre_scores_gemma":[0.968708,0.004963569,0.002630529,0.003828855,0.0005922267,0.00618083,0.008278637,0.00008821901,0.004729225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006004964,"threshold_uncertainty_score":0.02008861,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1925745319882942,"score_gpt":0.4948396367741353,"score_spread":0.3022651047858411,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}